Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neuromuscular Disorders

• Publication date

  2006-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.NMD.2006.03.002PMID 16616848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rituximab in the treatment of dermatomyositis: an open-label pilot study.

  2005cited by this paper
• Efficacy of rituximab in refractory polymyositis.

  2005cited by this paper
• Reactivation of hepatitis B virus with rituximab

  2005cited by this paper
• Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

  2004cited by this paper
• Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.

  2004cited by this paper
• Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

  2004cited by this paper
• Autoantibody profiles in the sera of European patients with myositis

  2001cited by this paper
• Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis.

  1992cited by this paper
• A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups

  1991cited by this paper
• Antibody to signal recognition particle in polymyositis.

  1990influential reference

• Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies

  2024cites this paper
• Plasma Exchange in Anti-Signal Recognition Particle Myopathy: A Systematic Review and Combined Analysis of Patient Individual Data

  2024cites this paper
• Immune-Mediated Necrotizing Myopathy Associated With Anti-signal Recognition Particle Antibody Complicated With Acute Respiratory Distress Syndrome: A Report of Two Cases

  2024cites this paper
• Pathogenesis and Treatment in IMNM

  2023cites this paper
• Miopatías Necrotizantes Autoinmunes: Reconocimiento como nuevo subgrupo de Miopatía Inflamatoria Idiopática

  2023cites this paper
• Dermatomyositis: A Comprehensive Review of a Complex Autoimmune Disease

  2023cites this paper
• The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.

  2022cites this paper
• Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy

  2022cites this paper
• Current and new targets for treating myositis.

  2022cites this paper
• Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature

  2021influential citation
• Therapeutic Management of Immune-Mediated Necrotizing Myositis

  2021cites this paper
• Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series

  2021cites this paper
• Myopathy associated with anti-signal recognition particle antibodies with pulmonary involvement and response to rituximab

  2021cites this paper
• Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report

  2020cites this paper
• The expression of BAFF in the muscles correlate with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies

  2020cites this paper
• Immune-Mediated Necrotizing Myopathy with Anti-SRP Autoantibodies and Typical Clinical Presentation

  2020cites this paper
• Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies

  2020cites this paper
• Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy.

  2019cites this paper
• In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy

  2018cites this paper
• Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies

  2018cites this paper
• Anti-SRP antibody related inflammatory myositis: A heterogeneous group of necrotizing myositis

  2018cites this paper
• Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.

  2018cites this paper
• Revision Dermatomyositis

  2018cites this paper
• Tratamiento con rituximab para las miopatías necrosantes autoinmunes asociadas al anti-SRP: caso clínico y revisión de la evidencia

  2018cites this paper
• Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.

  2018cites this paper
• Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics

  2017cites this paper
• Biologics for idiopathic inflammatory myopathies

  2017cites this paper
• Tratamiento con rituximab para las miopatías necrosantes autoinmunes asociadas al anti-SRP: caso clínico y revisión de la evidencia

  2017cites this paper
• Juvenile dermatomyositis with anti-signal recognition particle antibodies: a case report.

  2016cites this paper
• Idiopathic inflammatory myositis.

  2016cites this paper
• Necrotizing Autoimmune Myopathy

  2016cites this paper
• Efficacy and safety of rituximab in rheumatic diseases

  2015cites this paper
• Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management

  2015cites this paper
• Treatment of inflammatory myopathy: emerging therapies and therapeutic targets

  2015cites this paper
• Diagnostic Utility of Auto-Antibodies in Inflammatory Muscle Diseases

  2015cites this paper
• 無症候性高CK血症で長期経過した慢性型抗signal recognition particle（SRP）抗体陽性ミオパチーの壮年期男性例

  2015cites this paper
• [A case of chronic myopathy associated with an antibody to signal recognition particle (SRP) following long-term asymptomatic hypercreatinekinasemia].

  2015cites this paper
• Immune-Mediated Necrotizing Myopathy, Associated With Antibodies to Signal Recognition Particle, Together With Lupus Nephritis: Case Presentation and Management

  2015cites this paper
• Immune-mediated necrotising myopathy associated with antibodies to the signal recognition particle treated with a combination of rituximab and cyclophosphamide

  2015cites this paper
• [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].

  2014cites this paper
• [A case of an anti-SRP myopathy with enlargement of the thymus].

  2014cites this paper
• [Necrotizing myopathies: From genetic to acquired forms].

  2014cites this paper
• Successful treatment of refractory anti-signal recognition particle myopathy using abatacept.

  2014cites this paper
• Update on the treatment of myositis

  2014cites this paper
• B-Cell Targeted Therapies in Systemic Sclerosis and Inflammatory Myopathies

  2014cites this paper
• 胸腺腫大をともなう抗signal recognition particle抗体陽性ミオパチーの1例

  2014cites this paper
• Prise en charge thérapeutique des polymyosites, dermatomyosites, myosites de chevauchement et myopathies nécrosantes auto-immunes

  2014cites this paper
• Myopathies nécrosantes : des formes héréditaires aux formes acquises

  2014cites this paper
• Monoclonal antibodies in neuroinflammatory diseases

  2013cites this paper
• Acquired necrotizing myopathies

  2013cites this paper
• Signal recognition antibody-positive myopathy and response to intravenous immunoglobulin G (IVIG).

  2013cites this paper
• Complement-mediated muscle cell lysis: a possible mechanism of myonecrosis in anti-SRP associated necrotizing myopathy (ASANM).

  2013cites this paper
• [Acquired necrotizing myopathies].

  2013cites this paper
• Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide

  2012cites this paper
• Review: Immune‐mediated necrotizing myopathies – a heterogeneous group of diseases with specific myopathological features

  2012cites this paper
• Anticuerpos monoclonales en patología inflamatoria del sistema nervioso periférico y músculo

  2012cites this paper
• [Necrotizing myopathy associated with anti-SRP auto-antibodies: transient efficacy of a therapeutic strategy associating plasma exchanges and rituximab].

  2012cites this paper
• Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.

  2012cites this paper
• Therapeutic advances in myositis

  2012cites this paper
• [Atypical distribution of muscular atrophy in a 29-year-old man with polymyositis and anti-SRP antibodies].

  2012cites this paper
• Anticorps dans les myopathies auto-immunes

  2012cites this paper
• Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.

  2012cites this paper
• Monoclonal antibodies in inflammatory disease of the muscle and peripheral nervous system

  2012cites this paper
• [Monoclonal antibodies in inflammatory disease of the muscle and peripheral nervous system].

  2012cites this paper
• Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use.

  2011cites this paper
• [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].

  2011cites this paper
• Interstitial Lung Disease Associated with Clinically Amyopathic Dermatomyositis

  2011cites this paper
• Rituximab in myositis.

  2011cites this paper
• Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry.

  2011cites this paper
• Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

  2011cites this paper
• Myositis or dystrophy? Traps and pitfalls.

  2011cites this paper
• Therapeutic Approaches in Myositis

  2011cites this paper
• Therapy of polymyositis and dermatomyositis.

  2011cites this paper
• Rôle des lymphocytes T régulateurs dans un nouveau modèle murin de myopathie inflammatoire et implications dans la physiopathologie et la thérapie de la Myosite à Inclusions

  2011cites this paper
• Médecine interne et réanimation — Polymyosites et dermatomyosites

  2011cites this paper
• Clinical trials roundup in idiopathic inflammatory myopathies

  2011cites this paper
• [Off-label use of biological therapies in systemic diseases].

  2010cites this paper
• Comment traiter une myopathie inflammatoire de l’adulte ?

  2010cites this paper
• Rituximab therapy for myopathy associated with anti–signal recognition particle antibodies: A case series

  2010cites this paper
• Treatment of inflammatory muscle disease in adults.

  2010cites this paper
• Treatment-resistant inflammatory myopathy.

  2010cites this paper
• Médecine interne et réanimation — Polymyosites et dermatomyosites Internal medicine and intensive care — Polymyositis and dermatomyositis

  2010cites this paper
• Immunité innée, balance th1/th17 et précurseurs musculaires dans les myopathies inflammatoires

  2010cites this paper
• Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies

  2010cites this paper
• Non-infectious endocarditis in a patient with cANCA-associated small vessel vasculitis

  2009cites this paper
• [New autoantibodies in dermatomyositis].

  2009cites this paper
• Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature.

  2009cites this paper
• Treatment of Adult Inflammatory Myositis With Rituximab: An Emerging Therapy for Refractory Patients

  2009cites this paper
• Nuevos autoanticuerpos en la dermatomiositis

  2009cites this paper
• New Antibodies in Dermatomyositis

  2009cites this paper
• Rituximab et traitement des maladies auto-immunes et inflammatoires systémiques

  2009influential citation
• [Inflammatory myopathies: diagnosis and classifications].

  2009cites this paper
• mAbs in nonlupus autoimmune rheumatic disease

  2009cites this paper
• [Treatment of systemic autoimmune and inflammatory diseases with rituximab].

  2009cites this paper
• [Dermatomyositis].

  2009cites this paper
• B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.

  2008cites this paper
• Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion.

  2008cites this paper
• Therapeutic apheresis for myositises.

  2007cites this paper
• Actualités des myopathies inflammatoires : nouvelles classifications, critères diagnostiques, histopathologie, et traitements

  2007cites this paper
• Nouvelles classifications et physiopathologie des myopathies inflammatoires

  2007cites this paper